Cargando…

Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?

Detalles Bibliográficos
Autores principales:	Oh, Joo Hyun, Sinn, Dong Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121279/ https://www.ncbi.nlm.nih.gov/pubmed/36935649 http://dx.doi.org/10.3350/cmh.2023.0054

Ejemplares similares

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
por: Oh, Joo Hyun, et al.
Publicado: (2023)

Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]
por: Oh, Joo Hyun, et al.
Publicado: (2023)

Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”
por: Emiroglu, Halil Haldun
Publicado: (2023)

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2021)

The imitator of immune-tolerant chronic hepatitis B: A killer in disguise
por: Hur, Moon Haeng, et al.
Publicado: (2023)

Postpartum Hepatic Flares in Immune-Tolerant Pregnant Patients with Chronic Hepatitis B Virus Infection
por: Song, Myeong Jun
Publicado: (2022)

Liver biopsy interpretation & the regression of hepatitis B virus related cirrhosis
por: Grizzi, Fabio, et al.
Publicado: (2014)

The truth of the matter: will immune-tolerant chronic hepatitis B patients benefit from antiviral treatment?
por: Jeng, Wen-Juei, et al.
Publicado: (2023)

Efficacy of Antiviral Treatment in Liver Biopsy-Proven Immune-Tolerant Chronic Hepatitis B Patients: A Retrospective Cohort Study
por: Liu, Na, et al.
Publicado: (2021)

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
por: Song, Byeong Geun, et al.
Publicado: (2023)

Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?
por: Lee, Hyun Woong
Publicado: (2020)

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?
por: Sinn, Dong Hyun, et al.
Publicado: (2014)

Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks
por: Kennedy, Patrick T. F., et al.
Publicado: (2017)

Unresolved issues of immune tolerance in chronic hepatitis B
por: Lee, Hye Won, et al.
Publicado: (2020)

The Rate of Conversion from Immune-tolerant Phase to Early Immune-clearance Phase in Children with Chronic Hepatitis B Virus Infection
por: Hong, Suk Jin, et al.
Publicado: (2014)

The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B
por: Mao, Xianhua, et al.
Publicado: (2023)

Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
por: Yoo, Jeong-Ju, et al.
Publicado: (2023)

Immune Response to Hepatitis B Vaccine in Patients with Chronic Kidney Disease
por: Einollahi, Behzad
Publicado: (2011)

Discordance between Liver Biopsy and FibroTest in Assessing Liver Fibrosis in Chronic Hepatitis B
por: Park, Mi Sung, et al.
Publicado: (2013)

A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection
por: Zeng, Da-Wu, et al.
Publicado: (2016)

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
por: Yo, In Ku, et al.
Publicado: (2015)

The latest global burden of liver cancer: A past and present threat
por: Oh, Joo Hyun, et al.
Publicado: (2023)

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
por: Jeon, Mi Young, et al.
Publicado: (2021)

Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis
por: Lee, Han Ah, et al.
Publicado: (2023)

Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy
por: Malekzadeh, Reza, et al.
Publicado: (2011)

Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure
por: Ha, Jung Min, et al.
Publicado: (2015)

Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
por: Ahn, Jem Ma, et al.
Publicado: (2015)

Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”
por: Chu, Chia-Ming, et al.
Publicado: (2023)

Biopsy or cytology for diagnosing hepatic focal lesions?
por: Kim, Haeryoung
Publicado: (2021)

Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection
por: Jin, Young-Joo, et al.
Publicado: (2014)

The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
por: Jin, Young-Joo
Publicado: (2023)

Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients
por: Tatar, Bengü, et al.
Publicado: (2020)

Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection
por: Wang, Mingjie, et al.
Publicado: (2021)

Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”
por: Yoo, Jeong-Ju, et al.
Publicado: (2023)

Entecavir and Hepatitis B Immune Globulin in Patients Undergoing Liver Transplantation for Chronic Hepatitis B
por: Perrillo, Robert, et al.
Publicado: (2013)

On the future of therapeutic vaccination in chronic hepatitis B
por: Aguilar Rubido, Julio Cesar
Publicado: (2019)

Targeting MITF in the tolerance-phase
por: Arozarena, Imanol, et al.
Publicado: (2016)

Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B
por: Choi, Jonggi
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s0956j91gvmp7akhod84tm3srv